Add-on Pentoxifylline to Losartan Versus Increasing Dose of Losartan on NT-PRO BNP in Type 2 Diabetics With Nephropathy
Status:
Completed
Trial end date:
2015-09-01
Target enrollment:
Participant gender:
Summary
This study was designed to assess the efficacy of adding pentoxifylline to losartan in
comparison with increasing dose of losartan in type 2 diabetes patients with nephropathy.
also the effect of pentoxifylline on N terminal brain natriuretic peptide (NT-pro BNP) and
C-reactive protein